Skip to content
ClinCalc Pro
Menu
Sedating H1 antihistamine

Chlorphenamine maleate

Brand names: Piriton

Chlorphenamine maleate is a first-generation sedating antihistamine used in the emergency management of acute allergic reactions and anaphylaxis, and for symptomatic relief of urticaria and pruritus.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It competitively antagonises histamine at H1 receptors, reducing histamine-mediated vasodilatation, increased capillary permeability and pruritus; its lipophilicity allows CNS penetration, producing sedation.

Prescribing in practice

  • In anaphylaxis it is an adjunct only and must never delay or replace intramuscular adrenaline, which is the first-line life-saving treatment.
  • It has marked sedative and antimuscarinic effects, so caution is needed in the elderly, in prostatic hypertrophy, glaucoma and where alertness must be maintained.
  • The intravenous route should be given by slow injection, as rapid administration can cause transient hypotension and CNS stimulation.

Monitoring

Monitor for excessive sedation, anticholinergic effects and, after parenteral use, blood pressure and conscious level.

Counselling the patient

  • This medicine commonly causes drowsiness; avoid driving or operating machinery if affected.
  • Alcohol and other sedatives will increase the drowsiness.
  • Seek urgent help if allergic symptoms return or worsen after treatment.

Evidence & guidelines

Use as an adjunct in anaphylaxis after adrenaline is supported by UK Resuscitation Council guidance.

Reference: Resus Council UK anaphylaxis guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.

📚 MRCEM Revision

Featured in these MRCEM clinical pathways

Chlorphenamine maleate is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.

MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.